Nomenclature
To simplify the NMR assignment of the trimers, the following nomenclature is used. The monomers constituting the trimers are considered separately, numbered 1 to 3 starting from the N-terminus, and the glycine is numbered 4. All the monomers are numbered following the same standard system: the carbon bearing the carboxylic acid is C1 and the one bearing the amine is C4. The carbon attached to the nitrogen is Cα, and the numbering of the aliphatic part of the chain continues with Cβ, etc. The numbering of the protons corresponds to the numbering of the carbons. For clarity purposes, the monomer number is added as a prefix to the proton number. In the case of O-substituted compounds, a first number indicates the monomer bearing the side chain. A second number followed by O specifies the position of the functionalised oxygen. The aliphatic protons are numbered Hα, Hβ, etc. Triazole protons are indicated as HT. 
2-H5

Monomer Synthesis
The general synthetic route used to obtain the monomers required for trimer synthesis are shown below. All building blocks were synthesized as described previously with the exception of building blocks 12 and 22. 1, 2 These are described here. MeOH:THF 1:1 NaOH r.t., 2 days X = OCH 2 CCH 10 X = H 11
Scheme S1: Synthetic route used to prepare the monomers needed for trimer synthesis.
4-[(2-methylpropyl)amino]-3-(prop-2-yn-1-yloxy)benzoic acid 12
4-amino-3-(prop-2-yn-1-yloxy) benzoic acid 10 (3.92 g, 20.5 mmol), isobutyraldehyde (1.87 mL, 20.5 mmol) and picoline borane (2.63 g, 24.6 mmol) were stirred in methanol (100 mL) at room temperature for 3 hours. The solvent was evaporated, the obtained residue was dissolved in ethyl acetate (100 mL) and washed with a 1M aqueous solution of HCl (50 mL). The organic layer was dried over MgSO 4 and filtered, the filtrate concentrated under vacuum to give the desired product as a pale yellow solid (5.08 g, quant. 
General Trimer Synthesis Procedure
Glycine loaded Wang resin (0.79 mmol.g -1 , 100-200 mesh; carrier: polystyrene, crosslinked with 1% DVB; 127 mg, 0.1 mmol) was swelled in anhydrous DMF (5 mL) 15 minutes prior to reaction. The appropriate monomers (0.5 mmol) were dissolved in anhydrous chloroform (5 mL each) and preactivated for coupling with Ghosez's reagent (20% in chloroform, 0.45 mmol) for 1 hour at room temperature. The reactions were carried out on a CEM Liberty® automated microwave assisted peptide synthesizer, using a double coupling method: two times 20 minutes under microwave heating at 60°C. Before each coupling, standard washing and deprotection (25% piperidine solution in DMF) cycles were carried out on the synthesizer. The samples on resin were washed with dichloromethane and ether. When required, cleavage off the resin was performed manually, using a 50% solution of TFA in dichloromethane (2 mL). TFA was removed by bubbling the solution with nitrogen and the solvent was evaporated under vacuum.
General Click-Chemistry Procedure
The trimer on resin was swelled in THF or DMF (1 mL). Azidobiotin or FITC-azide (0.1 mmol), water (1 mL), copper (II) sulphate (0.01 mmol) and sodium ascorbate (0.02 mmol) were added in that order. The reaction was carried on the spinner for 16 hours. Addition of more equivalents of reagents was sometimes required to observe the completion of the reaction. The resin was then washed with water, dichloromethane and ether and the trimer was cleaved off the resin using a 50% solution of TFA in dichloromethane (2 mL). TFA was removed by bubbling the solution with nitrogen and the solvent was evaporated under vacuum.
Trimers 2 to 6, Biotin-2 to Biotin-6, and Flu-2 were previously described and characterised. 3
(4-(N-isobutyl-4-(N-isobutyl-4-(isobutylamino)benzamido)-3-((1-(3-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)propyl)-1H-1,2,3-triazol-4-yl)methoxy)benzamido)benzoyl)glycine 1
The monomer 26 (624 mg, 1.5 mmol) was used. The product was collected as a brown solid and used without further purification (57.9 mg, 96%). 
(4-(N-isobutyl-4-(N-isobutyl-4-(isobutylamino)benzamido)-3-((1-(3-(4-(2-oxohexahy-dro-1H-thieno[3,4-d]imidazol-4-yl)butanamido)propyl)-1H-1,2,3-triazol-5-yl)methoxy)-benzamido)benzoyl)glycine Biotin-1
The monomers 26 (415 mg, 1.0 mmol) and 22 (234 mg, 0.5 mmol) were used. A small amount of the sample was cleaved off the resin with TFA (50% in dichloromethane) to confirm the structure. 
5-(3-(3-(4-((5-((4-((carboxymethyl)carbamoyl)phenyl)(isobutyl)carbamoyl)-2-(N-isobutyl-4-(isobutylamino
5-(3-(3-(4-((5-((4-((carboxymethyl)carbamoyl)phenyl)(cyclohexylmethyl)carbamoyl)-2-(N-(naphthalen-2-ylmethyl)-4-(phenethylamino)benzamido)phenoxy)methyl)-1H-1,2,3-triazol-1-yl)propyl)ureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid Flu-2rev
The monomers 27 (232 mg, 0.5 mmol) and 24 (277 mg, 0.5 mmol) and 30 (228 mg, 0.5 mmol) were used. A small amount of the sample was cleaved off the resin with TFA (50% in dichloromethane) to confirm the structure. The observed mass corresponds to fragmentation of Flu-2rev.
Phage Display
Phage Display The Affimer library was prepared by the BioScreening Technology Group in the School of Molecular and Cellular Biology. 4 The phage display procedure is represented in Figure S 1. Biotinylated trimers (5 μl, 1 mM in DMSO) were bound to streptavidin-coated wells (Pierce) for 1 h, then 10 12 colony-forming units pre-panned phage were added for 2 hour with shaking (Heidolph VIBRAMAX 100). Panning wells were washed 6 times and eluted with glycine-HCl (0.2 mM, pH 2.2) for 10 min, neutralised with Tris-HCL (1M, pH 9.1), further eluted with triethylamine (100 mM) for 6 min, and neutralised with Tris-HCl (1M, pH 7). Eluted phage were used to infect ER2738 cells for 1 hour at 37°C and 90 rpm then plated onto LB agar plates with 100 mg/ml carbenicillin and grown overnight. Colonies were scraped into 5 ml of 2TYcarb (2TY containing 100 μg/ml carbenicillin) medium, inoculated in 25 ml of 2TYcarb and infected with ca. 1x10 9 M13K07 helper phage. After 1 h at 90 rpm, kanamycin was added to 25 mg/ml for overnight at 25°C and 170 rpm. Phage were precipitated with 20% polyethylene glycol 8000, 0.3 M NaCl and resuspended in 1 ml of TE buffer (Tris 10 mM, pH 8.0, 1 mM EDTA). A 2 ml aliquot of phage suspension was used for the second round of selection using streptavidin magnetic beads (Invitrogen) labelled with 15 μl of the biotinylated target (1 mM in DMSO). The beads were washed and incubated with prepanned phage for 1 h then washed five times using a KingFisher robotic platform (ThermoFisher) and eluted and amplified as above. The third pan used Neutravidin High Binding Capacity plates (Pierce), as previously described for panning round one, and the fourth pan followed the procedure from panning round one. Phage were recovered from wells containing target protein and control wells to determine the level of amplification in target wells.
Phage ELISA Individual ER2738 colonies were grown in 100 ml of 2TY with 100 mg/ml of carbenicillin in a 96-deep well plate at 37°C (1050 rpm) for 6 hours. A 25 ml aliquot of the culture was added to 200 ml of 2TYcarb and grown at 37°C (900 rpm) for 1 hour. Helper phage (10 l of 10 11 /ml) were added, followed by kanamycin to 25 mg/ml overnight and incubated at 25°C, 750 rpm. Streptavidin-coated plates (96 Maxisorp Nunc-Immuno Plate (Thermo Scientific) incubated with Streptavidin (5 g/ml) for 4 hours) were blocked with 2x casein blocking buffer (Sigma) overnight at 37°C. The plates were incubated with the biotinylated trimers for 1 hour, and 40 l of phage containing growth medium was added and incubated for 1 hour. Following washing, phage were detected by a 1 : 1000 dilution of Anti-FdBacteriophage-HRP (Seramun) for 1 hour, visualised with 3,3',5,5'-tetramethylbenzidine (TMB) (Seramun) and measured at 620 nm.
The reading of the phage ELISA plates is shown in Figure S2 . The results yielded high numbers of selective binders for Biotin-1 and Biotin-2 and we decided to focus our work on those two trimers. Biotin-3, -4, -5 and -6 generated fewer binders although Biotin-6 generated a number of selective affimers. The reasons for this are unclear but are likely related to the composition of side chains on these foldamers being unable to effectively present recognition handles for the affimers. Biotin-3 to -6 were initially chosen as they were good hits for p53-hDM2 inhibition, 3 so the number of affimers and selectivities do not relate to their ability to adopt an α-helix mimicking conformation.
For the Affimers raised against Biotin-1 and Biotin-2, the plasmid DNA was extracted from selected hits using a QIAprep Spin Miniprep Kit (QIAGEN), and sequenced using a T7P primer by Beckman Coulter Genomics. The sequences are shown in Table S 1.
During the selection of Affimers for Biotin-1 and -2, no pattern of amino acids stands out. Nevertheless, we can note that overall, non-polar or polar neutral amino acids tends to be predominant in the Affimer sequences, and polar positive amino acids outnumber polar negative amino acids. This can be explained by the presence of the carboxylic acid at the bottom of the foldamer, which is deprotonated under the conditions of the selection (pH 7). 
Affimer production
The Affimers were prepared following the previously published procedure. 4 A 15% SDS-PAGE gel was ran to check their purity and the Affimers were also analysed by HRMS (Table S2) . (Thermo Scientific) were pre-blocked with 200 μl 2x Blocking Buffer (BB) and incubated overnight at 0°C. Both plates were washed with 300 μl of PBST. 30 μl of the biotinylated targets (30 M in DMSO) was placed in each streptavidin-coated well. For negative control wells, 2x BB was used instead. The targets were incubated at room temperature on a platform shaker twice for 45 minutes, and washed with 300 μl of PBST between each incubation. The dilution was prepared in the F96 NuncImmuno Plate and incubated for 1 hour (Direct titration: The Affimer was serially diluted in filtered sterilised water. Competition assay: The competitor was serially diluted in filtered sterilised water with 5% DMSO, and the Affimer was added). The Streptavidin plate was washed with 300 μl of PBST, and the Affimer and/or competitor was transferred into it and incubated for 1 hour. The plate was then washed with 300 μl of PBST, and 50 μl of anti-6X his-tag HRP (abcam, diluted 5000 times in 2x BB from the commercial bottle) was added to the wells. The plate was incubated for 1 hour and washed 3 times with 300 μl of PBST. 50 μl of TMB (SeramunBlau® fast TMB/substrate solution) was added to the wells and allowed to develop for 15-30 minutes and the absorbance was measured at 620 nm on a Thermo Multiskan Ascent. Each experiment was run in triplicate and the normalised data was plotted to a sigmoidal fit in Origin 7 to determine the EC 50 or IC 50 . 
Fluorescence Anisotropy
The buffer used were either Water (filtered sterilised water + 3% DMSO), Phosphate Buffer (40 mM sodium phosphate, 200 mM sodium chloride, 0.02 mg ml-1 bovine serum albumin, pH 7.50) or TrisTriton buffer (50 mM Tris, 150 mM sodium chloride, 0.01% Triton, pH 7.40). The Affimer was serially diluted in a 96-well Optiplate and the Flu-trimer was added. The plates were allowed to incubate at room temperature for 45 minutes. Each experiment was run in triplicate and the fluorescence anisotropy measured using a Perkin Elmer EnVision TM 2103 MultiLabel plate reader, with excitation at 480 nm and emission at 535 nm (30 nM bandwidth) and the intensity (Eq. 1) was calculated for each point. This was used to calculate anisotropy (Eq. 2) and plotted to a sigmoidal fit in Origin 7 to determine the minimum and maximum anisotropies (r min and r max ). Using equation 3, the data for the anisotropy was converted to fraction bound and multiplied by the Flu-trimer concentration then fitted in origin 7 (Eq. 4) to give the dissociation constant K d . From a plot of intensity (Eq. 1) against concentration of protein λ was calculated to be 1. For Flu-2rev against 2-AF25, the value of anisotropy being around 0.25 suggested there could be some non-selective interaction between the compound and the plate. To address this question, we used a special non-stick plate (orange graph) and the new measurements were indeed around 0. Nevertheless, in all cases when we could not obtain a binding curve, low values in Affimer concentration lead to less accurate values in anisotropy that could not be interpreted due to the error.
